All translations

Enter a message name below to show all available translations.

Found 2 translations.

Name	Current message text
^h English (en)	The efficacy and safety of icosapent ethyl were established in a study with 8,179 participants who were either 45 years and older with a documented history of coronary artery, cerebrovascular, carotid artery and peripheral artery disease or 50 years and older with diabetes and additional risk factors for cardiovascular disease. Participants who received icosapent ethyl were significantly less likely to experience a cardiovascular event, such as a stroke or heart attack.
^h Japanese (ja)	イコサペントエチルの有効性と安全性は、冠動脈、脳血管、頸動脈、末梢動脈疾患の既往歴が記録されている45歳以上、または糖尿病と心血管疾患の追加危険因子を有する50歳以上の参加者8,179人を対象とした試験で確立された。イコサペントエチルを投与された参加者は、脳卒中や心臓発作などの心血管イベントを経験する可能性が有意に低かった。